$2.88-1.71%
2026-10-07 close · prelimSAB Biotherapeutics's published financial data is dated 2026-10-04. 2024 revenue was $1M. 2024 operating profit was −$43M.
Reported results
Quantus Signal · live data · not investment advice · Privacy Policy
SAB Biotherapeutics's published financial data is dated 2026-10-04. 2024 revenue was $1M. 2024 operating profit was −$43M.